CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to PHM.MC

Polyethylene Glycol-treated Human Immunoglobulin (VGIH)

Phase 3
PharmaMar, S.A. (PHM.MC)

Phase 3

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin

View Full Landscape
Drug Information

Target Indication

Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin

Clinical Trial

NCT01596335

Last updated: 7/31/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.